Research

From left, Xiang Ye, PhD, Suba Rajendren, PhD, Antiana Richardson, and John Karijolich, PhD, are studying how the cancer-causing virus KSHV commandeers host gene expression and regulatory machinery.
April 20, 2023

Study details RNA editing in virus-infected cancer cells

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection.

By Leigh MacMillan
April 20, 2023

Malin receives a Vanderbilt distinguished service award

Bradley Malin, PhD, has received one of Vanderbilt University’s top honors, the Alexander Heard Distinguished Service Professor Award.

By Bill Snyder
April 20, 2023

Pharmacology research symposium set for April 28

Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died last year.

By Bill Snyder
April 19, 2023

Four elected to the American Academy of Arts & Sciences

Four Vanderbilt University faculty members were recently elected to the American Academy of Arts & Sciences.

By Bill Snyder
April 13, 2023

Low-professionalism residents later draw higher patient complaints: study

A Vanderbilt study finds a strong association between lower ratings for interpersonal communication skills among medical residents in their last year of training and greater likelihood of unsolicited patient complaints among doctors during their first year of employment after training.

By Paul Govern
April 12, 2023

Research identifies new target that may prevent blood cancer

An international coalition of biomedical researchers co-led by Vanderbilt’s Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.

By Bill Snyder
April 11, 2023

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.
By Nancy Humphrey
April 11, 2023

COVID on Twitter: town vs. country

A natural language processing analysis of 407 million tweets from May 2020 to January 2022 captures the rural-urban divide regarding COVID-19.
By Paul Govern
April 10, 2023

The problem with the problem list

Algorithms to infer missing problems and suggest that they be added to electronic health records improved problem list completeness, with benefits for clinical care, patient comprehension of health conditions and population health.
By Paul Govern
April 6, 2023

A ‘supermere’ method for biomarker discovery

Vanderbilt researchers have developed a method for isolating extracellular vesicles and nanoparticles — a complex transport system involved in health and disease — which will improve biomarker discovery and the identification of therapeutic targets.
By Bill Snyder
April 5, 2023

Vanderbilt Prize Student Scholar nominations sought

Nominations for the 2023 Vanderbilt Prize Student Scholar are invited through April 28.
By Bill Snyder
March 30, 2023

New procedure helps patients avoid leg amputation

More than 75% of patients facing amputation from the most severe form of peripheral artery disease were able to keep their limb after an innovative treatment as part of a multicenter study published in the New England Journal of Medicine.
By Craig Boerner
March 30, 2023

NIH grant launches C. diff vaccine research initiative

Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.
By Anthony Czelusniak
1 … 25 26 27 28 29 … 127